Related Experiment Videos
Hemoglobin E-beta thalassemia: factors affecting phenotype
I Panigrahi1, S Agarwal, T Gupta
1Department of Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, U.P., India.
Indian Pediatrics
|May 7, 2005
Summary
Genetic factors influence E-beta-thalassemia severity. Xmn I polymorphism heterozygosity delays disease onset, aiding early diagnosis and management for better patient outcomes.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- E-beta-thalassemia presents with variable severity due to multiple genetic factors.
- Understanding these factors is crucial for effective patient management and diagnosis.
Purpose of the Study:
- To analyze the severity of E-beta-thalassemia.
- To correlate clinical presentation with hemoglobin E (HbE), hemoglobin F (HbF), E/F ratios, beta-globin gene mutations, and Xmn I polymorphism.
Main Methods:
- Studied 30 E-beta-thalassemia cases, focusing on clinical features and genetic markers.
- Quantified HbE using High-Performance Liquid Chromatography (HPLC).
- Analyzed Xmn I polymorphism and beta-mutations via Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) and Amplification Refractory Mutation System (ARMS), respectively.
Main Results:
- Common symptoms included pallor, splenomegaly, and hepatomegaly; 43% required regular transfusions at diagnosis.
- Heterozygosity for Xmn I polymorphism was associated with a later age of onset (>3 years) compared to homozygous absence (0.5-2.8 years).
- The IVS 1-5 (G-->C) beta-mutation was most prevalent (69.6%). A negative correlation existed between age of onset and HbE levels.
Conclusions:
- Clinical presentation aligns with previous findings in Thai populations.
- Xmn I polymorphism heterozygosity significantly delays disease onset.
- Early diagnosis is essential for timely management and prenatal diagnosis of E-beta-thalassemia.